Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 ISIN · CNE100006T44 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,125 across all filing types
Latest filing 2017-06-09 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
CLARIFICATION ANNOUNCEMENT
Board/Management Information Classification · 95% confidence The document is a clarification announcement related to a previous joint announcement about the appointment of directors. It corrects a typographical error regarding the age of an independent non-executive director. The content focuses on board composition and director information rather than financial data or report publication. The document length is short (1831 characters), and it is clearly an announcement clarifying director information, not a full report or financial statement. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2017-06-09 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 100% confidence The document provides an updated list of the company's Board of Directors, their roles, and committee memberships. It focuses solely on board composition and governance structure without any financial data, report publication, or voting results. There is no indication of an annual report, earnings release, or other financial filings. The content matches the description of Board/Management Information, which covers announcements of changes or updates in the company's board or senior management.
2017-06-07 English
JOINT ANNOUNCEMENT (A) DESPATCH OF COMPOSITE DOCUMENT IN RELATION TO MANDATORY UNCONDITIONAL CASH OFFER BY PLATINUM SECURITIES COMPANY LIMITED ON BEHALF OF CMBC INTERNATIONAL INVESTMENT LIMITED TO AC
M&A Activity Classification · 95% confidence The document is a joint announcement related to a mandatory unconditional cash offer to acquire shares, including the despatch of a composite document, appointment of directors, and changes in committee memberships. It references the Takeovers Code and includes detailed biographical information about newly appointed directors. The content focuses on corporate actions such as share acquisition offers and board changes rather than financial results or reports. The document is lengthy (15,000 characters) and contains substantive information about management changes and takeover activities. Therefore, it fits best under the category of M&A Activity (TAR) due to the takeover offer and related corporate announcements, and also includes Board/Management Information (MANG) elements. However, since the primary focus is on the takeover offer and the composite document dispatch, the most appropriate classification is M&A Activity (TAR).
2017-06-07 English
WHITE FORM OF ACCEPTANCE AND TRANSFER OF ORDINARY SHARE(S) OF CMBC CAPITAL HOLDINGS LIMITED
M&A Activity Classification · 95% confidence The document is a 'WHITE FORM OF ACCEPTANCE AND TRANSFER' related to an offer made by Platinum on behalf of the Offeror to acquire shares of CMBC Capital Holdings Limited. It is a form used by shareholders to accept a takeover offer, referencing a 'Composite Document' dated 7 June 2017. The content is procedural and legal in nature, instructing shareholders on how to accept the offer and transfer shares. This is not a report, financial statement, or announcement of voting results, but a form related to a takeover bid. Therefore, it fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2017-06-07 English
COMPOSITE DOCUMENT RELATING TO MANDATORY UNCONDITIONAL CASH OFFER BY PLATINUM SECURITIES COMPANY LIMITED ON BEHALF OF CMBC INTERNATIONAL INVESTMENT LIMITED TO ACQUIRE ALL THE ISSUED SHARES IN CMB
M&A Activity Classification · 100% confidence The document is titled as a "Composite Document" relating to a "Mandatory Unconditional Cash Offer" by Platinum Securities on behalf of CMBC International Investment Limited to acquire all issued shares in CMBC Capital Holdings Limited. It includes letters from the offeror, the board, independent board committee, and financial advisers, as well as appendices with financial information and terms of acceptance. The document is clearly related to a takeover bid or merger activity, involving an offer to shareholders to acquire shares. The presence of terms like "Offer", "Form(s) of Acceptance", "Takeovers Code", and detailed timetable for acceptance and closing date further confirm this. This type of document is typical for merger and acquisition activity filings. It is not an annual report, earnings release, or regulatory filing. It is not a proxy solicitation or voting results announcement. It is a detailed offer document related to a takeover bid, which fits the M&A Activity category (Code: TAR).
2017-06-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2017
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/05/2017. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content is focused on changes in the company's share capital structure during a specific month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting share capital movements to the Hong Kong Exchanges and Clearing Limited. This type of document fits best under 'Share Issue/Capital Change' (SHA) as it reports changes in share capital, including new shares issued, options, warrants, and other capital changes.
2017-06-05 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.